Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma

Between November 2012 and July 2014, in accordance with national law 648/96, brentuximab vedotin was available in Italy for patients with relapsed systemic anaplastic large cell lymphoma outside a clinical trial context. A large Italian observational retrospective study was conducted on the use of b...

Descripción completa

Detalles Bibliográficos
Autores principales: Broccoli, Alessandro, Pellegrini, Cinzia, Di Rocco, Alice, Puccini, Benedetta, Patti, Caterina, Gini, Guido, Mannina, Donato, Tani, Monica, Rusconi, Chiara, Romano, Alessandra, Vanazzi, Anna, Botto, Barbara, Carlo-Stella, Carmelo, Hohaus, Stefan, Musto, Pellegrino, Mazza, Patrizio, Molica, Stefano, Corradini, Paolo, Fama, Angelo, Gaudio, Francesco, Merli, Michele, Gravetti, Angela, Gritti, Giuseppe, Arcari, Annalisa, Tosi, Patrizia, Liberati, Anna Marina, Pinto, Antonello, Pavone, Vincenzo, Gherlinzoni, Filippo, Naso, Virginia, Volpetti, Stefano, Trentin, Livio, Goldaniga, Maria Cecilia, Bonfichi, Maurizio, De Renzo, Amalia, Schiavotto, Corrado, Spina, Michele, Storti, Sergio, Carella, Angelo Michele, Stefoni, Vittorio, Argnani, Lisa, Zinzani, Pier Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664397/
https://www.ncbi.nlm.nih.gov/pubmed/28775121
http://dx.doi.org/10.3324/haematol.2017.171355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664397/
https://www.ncbi.nlm.nih.gov/pubmed/28775121
http://dx.doi.org/10.3324/haematol.2017.171355

Ejemplares similares